Pulmonary
Partner With Us
Advertisement
Conexiant chevron_right Pulmonary chevron_right Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain
FDA & Government News

Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

Interim CDC estimates found the 2025–2026 vaccine reduced outpatient influenza visits by up to 41% and hospitalizations by up to 41%.

Conexiant

Clinical Scorecard: Flu Vaccine Cut Hospitalizations Despite Drifted H3N2 Strain

At a Glance

CategoryDetail
Condition
Key MechanismsVaccination reduces morbidity associated with influenza infections, with effectiveness estimates ranging from 22% to 41%.
Target Population
Care Setting

Key Highlights

  • Pediatric patients showed the strongest protection with hospitalization effectiveness at 38% to 41%.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

        • Consider potential unmeasured confounding factors in effectiveness studies, especially with antigenic drift.

        Patient & Prescribing Data

        Vaccination is crucial even with antigenic drift in circulating viruses; pediatric effectiveness estimates range from 38% to 41%.

        Clinical Best Practices

        • Encourage vaccination for all eligible persons aged 6 months and older.
        • Document vaccination status accurately to avoid misclassification.
        • Monitor for unmeasured confounding factors in effectiveness studies.

        Related Resources & Content

        Daily News

        Stay up to date with the latest clinical headlines and other information tailored to your specialty.